Graham Capital Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$181K Buy
18,496
+5,676
+44% +$56K ﹤0.01% 1067
2026
Q1
$125K Sell
12,820
-14,936
-54% -$137K ﹤0.01% 1013
2025
Q4
$265K Sell
27,756
-25,637
-48% -$261K 0.01% 914
2025
Q3
$521K Buy
53,393
+19,351
+57% +$149K 0.01% 597
2025
Q2
$207K Buy
+34,042
New +$255K ﹤0.01% 1124

Other funds holding PRTA

Graham Capital Management's PRTA Position: Q2 2026 in Review

Graham Capital Management increased its Prothena Corp (PRTA) stake by 44% in Q2 2026, buying an estimated $56K and bringing the position to 18,496 shares worth $181K. The position accounts for ﹤0.01% of the portfolio, ranked #1067.

Graham Capital Management first reported a position in PRTA in Q2 2025 and has held it in 5 quarters since. The position peaked at $521K in Q3 2025. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Graham Capital Management held 18,496 shares of Prothena Corp worth $181K as of Q2 2026.
  • Graham Capital Management bought 5,676 Prothena Corp shares in Q2 2026, an estimated $56K.
  • Prothena Corp made up ﹤0.01% of Graham Capital Management's portfolio in Q2 2026, its #1067 holding.
  • Graham Capital Management first reported a position in Prothena Corp in Q2 2025 and has held it in 5 quarters since.
  • Graham Capital Management's Prothena Corp position peaked at $521K in Q3 2025.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.